Britain's fertility watchdog agency has approved expanded screening of embryos to include genetic links to ovarian, breast and colon cancers.
At a meeting in Belfast, the Human Fertilization and Embryology Authority said pre-implantation genetic diagnosis could be done for the three cancers as part of in-vitro fertilization.
The agency already allows testing for certain gene mutations linked to serious conditions that occur in early childhood, such as cystic fibrosis and some cancers, The Independent reported.
The procedure entails removing a single cell from a fertilized embryo once it starts to divide in the laboratory. If genetic tests on that cell are normal, the embryo is implanted into the womb and the pregnancy continues normally.
HFEA Chairwoman Suzi Leather denied the approval was part of a slippery slope toward genetic testing for genetic characteristics.
"This is not about opening the door to wholesale genetic testing," she said. "This is about considering a particular group of genetic conditions to be sufficiently serious to merit the use of PGD embryo testing."
Copyright 2006 by United Press International
Related stories:
Gene directs stem cells to build the heart
Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.
First use of DNA fingerprinting to identify viable embryos
Fertility researchers have used DNA fingerprinting for the first time to identify which embryos have implanted after in vitro fertilisation (IVF) and developed successfully to result in the births of healthy babies. The technique, combined with sampling cells from blastocysts (the very early embryo) before implantation in the womb, opens the way to pin-pointing a handful of genes that could be used to identify those blastocysts most likely to result in a successful pregnancy.
Genetic defect links respiratory disease and congenital heart disease
The same genetic defect that causes a rare respiratory disease may also lead to some types of congenital heart disease, according to a study from the University of North Carolina at Chapel Hill School of Medicine.
DNA studies show 1 critically endangered grouper species is really 2
Researchers from the University of Hawaii, the Wildlife Conservation Society, Smithsonian Tropical Research Institute, National Marine Fisheries Service and Projecto Meros do Brazil discovered a new species of fish—a grouper that reaches more than six feet in length and can weigh nearly 1,000 pounds. This newly discovered species can be found roaming the tropical reefs of the Eastern Pacific Ocean.
Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model. In their report published in the journal
Stem Cells, the team from the MGH Center for Engineering in Medicine report that mesenchymal stem cells (MSCs), known to control several immune system activities, allowed the regeneration of the gastrointestinal lining in mice with a genetic mutation leading to multiorgan autoimmune disease.
Medicine tailored to your genome, not your race: Venter
Personalised, genome-based health care could help prevent hundreds of thousands of deaths caused each year by adverse drug reactions, genetics pioneer Craig Venter said Tuesday.
Tracking a crop disease could save millions of lives
Scientists have discovered why one of the world's most important agricultural diseases emerged, according to research published in the September issue of the
Journal of General Virology. Maize streak virus (MSV) causes the main virus disease of Africa's most important food crop. By comparing the genome of the virus to those of its less harmful relatives, scientists have discovered how and why MSV became a serious pest and spread so rapidly across Africa.
Immune response to human embryonic stem cells in mice suggests human therapy may face challenge
Human embryonic stem cells trigger an immune response in mice, researchers from the Stanford University School of Medicine report. The finding suggests that the effectiveness of human therapies derived from the cells could be limited unless ways are found to dampen the rejection response.